MP:0000062 | increased bone density | "increased mineral content of bone; indicator of bone strength" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:61295] |
Show
Allelic Composition: Aspatm1b(EUCOMM)Wtsi/Aspatm1b(EUCOMM)Wtsi Genetic Background: C57BL/6N-Aspatm1b(EUCOMM)Wtsi/Ieg
|
MP:0000693 | spleen hyperplasia | "increased cell number in the spleen" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:33401] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0000708 | thymus hyperplasia | "increased cell number in the thymus" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:33401] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0000716 | abnormal immune system cell morphology | "anomalous structure, development, or number of immune cells" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0001790 | abnormal immune system physiology | "deviation from the normal function of the immune system " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0001828 | abnormal T cell activation | "anomaly in the process of producing effector T cells from naive T cells" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0002425 | altered susceptibility to autoimmune disorder | "a change in the likelihood that an organism will develop disease characterized by production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0002497 | increased IgE | "greater than normal immunoglobulin class E level" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0002590 | increased mean corpuscular volume | "greater than the average amount of space occupied by each red blood cell, calculated from the hematocrit and red cell count, in erythrocyte indices" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Aspatm1b(EUCOMM)Wtsi/Aspatm1b(EUCOMM)Wtsi Genetic Background: C57BL/6N-Aspatm1b(EUCOMM)Wtsi/Ieg
|
MP:0002906 | susceptibility to pharmacologically induced seizures | "inability to withstand doses of pharmacological drugs that induce seizure activity in normal animals" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator, J:69504] |
Show
Allelic Composition: Apaf1fog/Apaf1Gt(IRESBetageo)XIX18Pgr Genetic Background: involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C3H/HeJ * NMRI
|
MP:0003960 | increased lean body mass | "more than average fat-free physical bulk or volume of the body including all its components except adipose tissue" [honda:Hiraoki Onda, Mouse GEnome Informatics Curator] |
Show
Allelic Composition: Aspatm1b(EUCOMM)Wtsi/Aspatm1b(EUCOMM)Wtsi Genetic Background: C57BL/6N-Aspatm1b(EUCOMM)Wtsi/Ieg
|
MP:0004794 | increased anti-nuclear antigen antibody level | "elevated level of antibodies to nuclear antigens present in the sera" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0005090 | increased double-negative T cells count | "greater than expected numbers of the subset of T cells found in the thymus that express neither CD4 nor CD8" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0005092 | decreased double-positive T cell count | "less than the expected number of the subset of T cells found in the thymus that express both CD4 and CD8" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0005095 | decreased T cell proliferation | "reduced clonal expansion of naive T cells in response to stimuli" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0005325 | abnormal glomerulus | "anomalous structure of the capillary loops of the kidney that normally function as a filtration unit" [J:57971, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0005463 | abnormal CD4+ T cell physiology | "anomalous response of the subset of T lymphocytes that carry the CD4 marker, recognize intravesicular peptides bound to MHC class-II molecules, and turn on antibody production" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0005561 | increased mean corpuscular hemoglobin | "greater than the average levels of hemoglobin contained in an erythrocyte" [RGD:Rat Genome Database submission, Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Aspatm1b(EUCOMM)Wtsi/Aspatm1b(EUCOMM)Wtsi Genetic Background: C57BL/6N-Aspatm1b(EUCOMM)Wtsi/Ieg
|
MP:0008074 | increased CD4-positive T cell number | "greater number of the subset of T lymphocytes that carry the CD4 marker, recognize intravesicular peptides bound to MHC class-II molecules, and turn on antibody production" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0008076 | abnormal CD4-positive T cell differentiation | "atypical production of or inability to produce the subset of T lymphocytes that carry the CD4 marker, recognize intravesicular peptides bound to MHC class-II molecules, and turn on antibody production" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0008078 | increased CD8-positive T cell number | "greater number of the regulatory subset of T lymphocytes that are involved in MHC class I restricted interactions" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0008102 | lymph node hyperplasia | "overdevelopment or increased size, usually due to increased cell number, in the lymph nodes" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0008478 | increased spleen white pulp amount | "increase in the quantity of the parenchymatous tissue of the spleen that surrounds splenic blood vessels, consists of compact masses of lymphatic cells and is where foreign material removed from the blood is used to initiate an immune reaction that results in the production of antibodies" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0008481 | increased spleen germinal center number | "greater number of spleen secondary B follicles where rapid B-cell proliferation, somatic hypermutation, and selection for antigen binding occurs" [PMID:17495967] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0008499 | increased IgG1 level | "greater than normal immunoglobulin class G1 level" [MGI:tmeehan "Terry Meehan, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0008522 | abnormal lymph node germinal center | "any strucutral anomaly of the area of the lymph node secondary follicle where B cells are stimulated by antigens and helper T cells are stimulated to generate memory cells" [MESH:A10.549.400.500, MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0008688 | decreased interleukin-2 secretion | "reduction in the production or release of a soluble substance elaborated by antigen- or mitogen-stimulated T-cells which induces DNA synthesis in naive lymphocytes" [MESH:D12.644.276.374.465.502] |
Show
Allelic Composition: Thrbtm1Df/Thrbtm1Df Genetic Background: involves: 129S1/Sv * C57BL/6J
|
MP:0010025 | decreased total body fat amount | "less than the normal total amount of connective tissue composed of fat cells within the entire body" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Aspatm1b(EUCOMM)Wtsi/Aspatm1b(EUCOMM)Wtsi Genetic Background: C57BL/6N-Aspatm1b(EUCOMM)Wtsi/Ieg
|
MP:0010123 | increased bone mineral content | "elevation in the amount (usually in grams/cm) of bone mineral divided by a bone-scanned area" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Aspatm1b(EUCOMM)Wtsi/Aspatm1b(EUCOMM)Wtsi Genetic Background: C57BL/6N-Aspatm1b(EUCOMM)Wtsi/Ieg
|
MP:0013278 | decreased fasted circulating glucose level | "reduction in the amount of glucose in the blood at some defined time point after eating compared to controls" [MGI:Armida_Di_Fenza] |
Show
Allelic Composition: Aspatm1b(EUCOMM)Wtsi/Aspatm1b(EUCOMM)Wtsi Genetic Background: C57BL/6N-Aspatm1b(EUCOMM)Wtsi/Ieg
|
MP:0013279 | increased fasted circulating glucose level | "increase in the amount of glucose in the blood at some defined time point after eating compared to controls" [MGI:Armida_Di_Fenza] |
Show
Allelic Composition: Aspatm1b(EUCOMM)Wtsi/Aspatm1b(EUCOMM)Wtsi Genetic Background: C57BL/6N-Aspatm1b(EUCOMM)Wtsi/Ieg
|
MP:0020467 | abnormal circadian behavior | "any anomaly in the specific behavior of an organism that recurs with a regularity of approximately 24 hours" [GO:0048512] |
Show
Allelic Composition: Nr2e3tm1Dgen/Nr2e3tm1Dgen Genetic Background: involves: 129P2/OlaHsd * C57BL/6J
Allelic Composition: Bhlhe40tm1Tan/Bhlhe40tm1Tan,Bhlhe41tm1Mjro/Bhlhe41+ Genetic Background: B6.129-Bhlhe40tm1Tan Bhlhe41tm1Mjro
Allelic Composition: Bhlhe40tm1Tan/Bhlhe40+,Bhlhe41tm1Mjro/Bhlhe41tm1Mjro Genetic Background: B6.129-Bhlhe40tm1Tan Bhlhe41tm1Mjro
|
MP:0020475 | delayed circadian behavior phase | "decrease in the phase relationship between a temporal synchronizing event (such as light cycle) and a behavioral phase reference point of an animal (such as activity onset)" [MGI:smb] |
Show
Allelic Composition: Nr2e3tm1Dgen/Nr2e3tm1Dgen Genetic Background: involves: 129P2/OlaHsd * C57BL/6J
Allelic Composition: Bhlhe40tm1Tan/Bhlhe40tm1Tan Genetic Background: B6.129-Bhlhe40tm1Tan
Allelic Composition: Bhlhe40tm1Tan/Bhlhe40tm1Tan,Bhlhe41tm1Mjro/Bhlhe41+ Genetic Background: B6.129-Bhlhe40tm1Tan Bhlhe41tm1Mjro
Allelic Composition: Bhlhe40tm1Tan/Bhlhe40+,Bhlhe41tm1Mjro/Bhlhe41tm1Mjro Genetic Background: B6.129-Bhlhe40tm1Tan Bhlhe41tm1Mjro
|